CollPlant Biotechnologies (CLGN) Enterprise Value Growth (1y) (2018 - 2026)
CollPlant Biotechnologies (CLGN) Enterprise Value Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 97.68% |
| Dec 31, 2025 | 97.71% |
| Sep 30, 2025 | 95.55% |
| Jun 30, 2025 | 38.89% |
| Mar 31, 2025 | 3.30% |
| Dec 31, 2024 | -763.34% |
| Sep 30, 2024 | -4.98% |
| Jun 30, 2024 | 14.35% |
| Mar 31, 2024 | -892.51% |
| Dec 31, 2023 | 85.05% |
| Sep 30, 2023 | -672.67% |
| Jun 30, 2023 | 38.69% |
| Mar 31, 2023 | 35.16% |
| Dec 31, 2022 | 99.91% |
| Sep 30, 2022 | -27.12% |
| Jun 30, 2022 | -106.53% |
| Mar 31, 2022 | 78.69% |
| Dec 31, 2021 | -5,746,140.84% |
| Sep 30, 2021 | -398.75% |
| Jun 30, 2021 | -360.09% |